Intensity Therapeutics Competitors and Similar CompaniesClear all
Intensity Therapeutics's competitors and similar companies include Acrivon and Numab.
 Intensity Therapeutics Intensity Therapeutics is a biotechnology company that develops intratumoral immunotherapy products. |  Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline. | ||
Founding Date | Founding Date 2012 | Founding Date 2018 | Founding Date 2011 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Shelton, US HQ | Locations Watertown, US HQ Lund, SE | Locations Wädenswil, CH HQ |
Employees | Employees 5150% increase | Employees 415% increase | Employees 681% decrease |
Valuation ($) | Valuation ($) 42.7 m | Valuation ($) 256.1 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($11.6m) (FY, 2025) | Net income ($77.9m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 11.5m | Total funding raised N/A | Total funding raised $ 132.3m |
For sources of this data, please see the company profile
View Company Profiles
Acrivon
HQ
Watertown, US
Employees
41↑ 5% increase
Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline.
View company
Numab
HQ
Wädenswil, CH
Employees
68↓ 1% decrease
Numab Therapeutics is an oncology-focused biopharmaceutical company.
View company